Thursday, June 18, 2009
"Libel Tourism" and England - Global Home for Libel Litigation ?
"Simon Singh completed a BSc in physics and a PhD in particle physics at Cambridge University before becoming a director and producer in the BBC science department. He worked on Tomorrow's World and Horizon and won a BAFTA for directing a documentary on the subject of Fermat's Last Theorem. After leaving the BBC, he wrote a series of bestselling popular science books, such as "Fermat's Last Theorem", "The Code Book" and "Big Bang". He has also presented several radio and TV programmes, and his educational initiatives include the Enigma Project and the Undergraduate Ambassadors Scheme. In 2003 he received an MBE for services to science education and communication."
Wednesday, June 17, 2009
Bankruptcy Court Releases of Tort Claims Against Non-debtors - Where and When Are Releases Proper ?
In other chapter 11 cases, the US Trustee's office in NY has recently objected to releasing non debtor parties when they have not made an extraordinary contribution to the bankruptcy estate, as I learned yesterday from reading LAW360 on bankruptcy. The objection was asserted in the Charter One bankruptcy, and is available here.
NonMalignant Claims Going Back Up If You Judge by the Manville Asbestos Trust Report for Q 1 2009
The visible and depressing part of the report involves nonmalignant claims - the ones that seemingly have been fading away. But, that's not true for Manville during the first quarter of 2009. Instead, nonmalignant claims went back up - significantly - contrary to prior trends. They are said to be category 2 nonmalignancies, which means "asbestosis/pleural plaques" with a scheduled payment of $12, 000 (subject to prorated payment ) under the terms of the 2002 Manville TDP procedures available here - see page 7.
Specifics? Doing a little math from figures shown in the report's cover letter to Judges Lifland and Weinstein, it looks like there were about 2,900 nonmalignant claims, which is far more claims than ALL the Manville claims filed in 1Q 2008. According to the report's cover letter:
"During the first quarter of 2009, the Trust received 4,853 new claim filings compared to 1,776 for the same period of 2008. The malignant filing population has accounted for approximately 40% of the total for the first quarter of 2009 claim filings compared to 68% for the first quarter of 2008. The percentage decrease in malignancies is attributed to the sharp increase in the filing of unimpaired non-malignant Level 2 claims." (emphasis added)
"The Trust settled 3,749 claims for $30.4 million during the first quarter 2009 compared to 1,582 claim settlements for $14.8 million during the same period of 2008. The average settlement amount for the first quarter of 2009 and 2008 was approximately $8,100 and $9,300, respectively. Once again, the decrease in the average settlement amount is due principally to the higher percentage of non-malignancy claims settled during the first quarter 2009."
Also depressing is the lack of data in the report to tell readers where these nonmalignant claims are coming from and the nature of the supporting proofs. Are these claims from persons resident in the US or persons who live overseas? Are some of these claims from older claimants who perhaps really did inhale large amounts of Manville fibers, or are some these claims from younger claimants with x-rays read by physicians of dubious repute who have not yet been banned from submitting the reports ? Or, are these all valid claims supported by sound medicine and science ? The report does not shed light on the answers to the questions. Once again, bankruptcy- related proceedings prove themselves to be the antithesis of transparency, and the Manville Data apparently remains unavailable, thus making it harder for anyone to figure out the real facts about tens of millions of dollars that perhaps should instead be available to be paid to mesothelioma claimants.
Sunday, June 14, 2009
In GM, Asbestos Claimants Request Appointment of a Futures Representative est Request for
"The Ad Hoc Committee of Asbestos Personal Injury Claimants is comprised of William J.
Lewis, a mesothelioma claimant with a settled but unpaid claim, represented by
SimmonsCooper LLC; Maureen Tavaglione, Personal Representative of the Estate of Robert
J. Tavaglione, represented by Waters & Kraus; Terry Roth, a lung cancer claimant,
represented by Brayton Purcell LLP; Jene Moore, Sr., a mesothelioma claimant represented
by Early Ludwick & Sweeney L.L.C.; Edward Levitch, a mesothelioma claimant represented
by Paul & Hanley LLP; and asbestos personal injury claimants represented by Cooney and
Conway; The Lanier Law Firm PLLC and Weitz & Luxemberg, P.C. Steven KazMcClain, Lyons, Greenwood & Harley, PLC, serves as an ex oficio member."
General Motors’ most recent Quarterly Report (Form 10-Q) filed with the
Securities and Exchange Commission admits that it has hired the firm of
“Hamilton Rabinovitz & Associates, Inc., a firm specializing in estimating
asbestos claims, to assist us in determining our potential liability for pending
and unasserted future asbestos personal injury claims.” After noting that
their estimates are “inherently subject to certain uncertainties” and that
their data sources and assumptions “may not prove to be reliable predictors
with respect to claims asserted against us,” General Motors states that its
“liability recorded for asbestos-related matters was $627 million, $648 million
and $628 million at March 31, 2009, December 31, 2008 and March 31, 2008
respectively.”
Experience suggests that these figures fall on the extreme low side of likely future asbestos liability.
Thus the magnitude of General Motors’ projected ongoing asbestos liability
has been a matter of public knowledge and should have been addressed by
both General Motors and the Auto Task Force in their restructuring
activities.
9. As stated in the Motion, to ensure that General Motors’
acknowledged future asbestos claimants are vigorously and faithfully
represented, a legal representative for future asbestos personal injury
claimants (a “Future Claimants’ Representative”) should be appointed at the
earliest possible date in order to take an “active and aggressive role” in
protecting their interests “at every step [of the] litigation.” Findley v. Falise
(In re Johns-Manville Corp.), 898 F.Supp. 473, 565 (S.D.N.Y. 1995).
Similarly, because the Sale Motion now before this Court seeks to affect the
rights of current asbestos claimants as well as future asbestos demand
holders, an Official Committee of Asbestos Personal Injury Claimants (an
“Asbestos Committee”) should be appointed as early in this bankruptcy case
committed, delaying appointment of a Future Claims’ Representative and an
Asbestos Committee would, in effect, deny unknown future asbestos
claimants the protections to which they are entitled and deny current
asbestos claimants any meaningful participation in these cases.
Preliminary Report In UK on Possible Changes to Assessment of Costs
A June 1, 2009 article in Business Insurance by Sarah Vesey provides a terse summary of the report. She comments:
"In the report, Justice Jackson said several potential changes to the existing cost regime for group actions "merit consideration."
Among them are instituting a no-cost-shifting rule; allowing cost-shifting for only part of the proceedings, for example only after the stage where a class wins certification; implementing a common funds doctrine, such as that used in the United States in which successful lawyers are entitled to have their fees reimbursed from the fund awarded to the class; public interest litigation, whereby the court has power to order that no cost-shifting occur when a group representative brings an action on an issue of public interest; and using a lower-cost scale for collective actions.
Justice Jackson said his "tentative view" to do away with cost-shifting for collective actions merits serious consideration in the second phase of his review and would, among other things, promote access to justice and be fairer for defendants."
Global Litigation Trends Article - Aggregate Litigation, Contingent Fees, Litigation Funding, and Punitive Damages
I particularly liked the article because it packs a material amount of information into 30 pages. The first two sections provide an overview of particular developments in aggregate litigation/class actions and some nation by nation citations to articles on aggregate litigation. Those highlights are followed in section III by an incredibly handy reference tool that provides a country by country synopsis of the aggregate litigation procedures increasingly available in countries ranging from Argentina to Taiwan, followed by a brief section IV addressing EU law aggregate litigation developments. Section V addresses developments in paying for litigation. First covered are changes around the world with respect to contingency fees (they are permitted more places than you might think - for example, Italy recently passed legislation to permit contingent fees), as well as uplift fees, success fees and multipliers. The section also touches briefly on the rise of litigation funding outside the US. Global developments in punitive damages are covered in section VI. The article provides cogent cites to demonstrate that new attitudes are developing outside the US with respect to non compensatory damages.
As the name of this blog reflects, it seems plain enough to me that tort litigation is indeed going global, albeit with regional and national twists, not to to mention the intricacies of comparing civil law countries to common law countries, as well as developments in Asia where some countries have this century essentially embarked anew in their approach to courts and law because past law was feudal or otherwise outmoded. I was curious though to read the the concluding remarks of Mark and his colleagues since they (like me) are not academics and represent the defense side in most cases. Here's what they had to say:
"A growing list of countries outside the United States, including Canada, Australia, most European, and several South American countries, now recognize some form of multiclaimant litigation— whether class actions, groups actions, or representative actions by consumer or public organizations. The trend, however, has been to reject wholesale adoption of U.S.-style class actions. What has emerged instead is a distinctly “un-American” approach that generally disfavors opt-out procedures and often allows public bodies and private consumer organizations to bring collective actions in addition to (and sometimes in place of) individuals. Foreign countries also have “not so far been inclined to change other rules that have helped make class action lawsuits practical in the United States.” In particular, there have not been widespread calls to do away with the loser-pays rule. Contingent fees and punitive damages remain generally prohibited, but changes are occurring in this area and past prohibitions are softening. The stepstaken so far in these two areas, in particular, have been incremental and modest—but a wall is built one brick at a time. If collective actions become more prevalent, and the foreign plaintiffs’ bar better funded and coordinated as a result, it would not be surprising to hear calls for broader and speedier reform."